Michael P. Miller
2017 - Jazz Pharmaceuticals
In 2017, Michael P. Miller earned a total compensation of $2.9M as Executive Vice President U.S Commercial at Jazz Pharmaceuticals, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $270,000 |
|---|---|
| Option Awards | $915,873 |
| Salary | $492,308 |
| Stock Awards | $1,176,530 |
| Other | $15,624 |
| Total | $2,870,335 |
Miller received $1.2M in stock awards, accounting for 41% of the total pay in 2017.
Miller also received $270K in non-equity incentive plan, $915.9K in option awards, $492.3K in salary and $15.6K in other compensation.
Rankings
In 2017, Michael P. Miller's compensation ranked 3,802nd out of 14,666 executives tracked by ExecPay. In other words, Miller earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,802 out of 14,666 | 74th |
Division Manufacturing | 1,324 out of 5,768 | 77th |
Major group Chemicals And Allied Products | 372 out of 2,074 | 82nd |
Industry group Drugs | 287 out of 1,730 | 83rd |
Industry Pharmaceutical Preparations | 228 out of 1,329 | 83rd |
Source: SEC filing on June 14, 2019.
Miller's colleagues
We found five more compensation records of executives who worked with Michael P. Miller at Jazz Pharmaceuticals in 2017.
2017
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2017
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2017
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2017
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2017
Karen Smith
Jazz Pharmaceuticals